|
|||||
|
|
Primary cells in BCR/FGFR1‐positive 8p11 myeloproliferative syndrome are sensitive to dovitinib,ponatinib, and dasatinib |
|
| Authors: | Niklas Landberg Arta Dreimane Marianne Rissler Rolf Billström Helena Ågerstam |
| Affiliation: | 1. Department of Clinical Genetics, Lund University, Lund, Sweden;2. Department of Haematology, Link?ping University Hospital, Link?ping, Sweden;3. Department of Medicine, Central Hospital Sk?vde, Sk?vde, Sweden |
| Abstract: | |
| Keywords: | myeloproliferative syndrome 8p11 myeloproliferative syndrome BCR/FGFR1 tyrosine kinase inhibitors |